Operator Good day, and thank you for standing by, and welcome to the Constellation Pharmaceuticals First Quarter 2021 Earnings Conference Call. [Operator Instructions] I would now like to hand the conference over to your speaker today, Kia Khaleghpour, Vice President of Investor Relations and Communications. Please go ahead. Kia Khalaghpour -- Vice President, Investor Relations and Communications Thank you, operator. Good morning, everyone, and welcome to this conference call to discuss Constellation's first quarter 2021 financial results and operational performance. Please turn to Slide 2. Before we begin, I want to point out that our presentation today will include forward-looking statements, which are subject to certain risks and uncertainties. Actual results may differ materially due to various important factors, including those described in the Risk Factors section as well as discussions of potential risks, uncertainties and other important factors in the company's most recent filings with the Securities and Exchange Commission, including the company's quarterly report on Form 10-Q for the first quarter ended March 31, 2021.